Enovis (ENOV) Amortization - Goodwill (2024 - 2025)

Enovis (ENOV) reported Amortization - Goodwill of $501.0 million for Q4 2025, down 22.33% year-over-year from $645.0 million in Q4 2024, and down 7.36% quarter-over-quarter from $540.8 million in Q4 2025.

Enovis (ENOV) Amortization - Goodwill (2024 - 2025) Analysis & Trends

Enovis (ENOV) has 2 years of Amortization - Goodwill data on file, last reported at $501.0 million in Q4 2025.

  • Amortization - Goodwill for Q4 2025 came in at $501.0 million, down 22.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.7 billion (changed N/A YoY), and the FY2025 annual result was $1.0 billion, up 62.75% from the prior year.
  • Amortization - Goodwill fell to $501.0 million in Q4 2025 per ENOV's latest filing, from $540.8 million in the prior quarter.
  • Over five years, Amortization - Goodwill peaked at $645.0 million in Q4 2024 and troughed at $501.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Enovis 1.24 Bn 1.21 Bn 365.49 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 501.00 Mn
Oct 3, 2025 540.80 Mn
Dec 31, 2024 645.00 Mn